STOCK TITAN

IDenta Corp - 2022 Annual Meeting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

IDenta Corp. (OTCQB: IDTA) will hold its 2022 Annual Shareholders' meeting on June 26, 2022, at 7:00 PM (GMT +3) in Jerusalem, Israel. The company specializes in developing Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives, and Forensic Products targeting Homeland Security and Consumer Markets. CEO Amichai Glattstein expressed enthusiasm for the upcoming meeting, looking forward to engaging with shareholders. The company is known for its innovative products, which adhere to the stringent standards of law enforcement and security agencies.

Positive
  • IDenta Corp. is a recognized leader in Field Detection and Home Diagnostics, enhancing its market position.
  • The upcoming Annual Shareholders' meeting indicates active shareholder engagement and transparency.
Negative
  • None.

WASHINGTON, June 7, 2022 /PRNewswire/ -- IDenta Corp. (OTCQB: IDTA) is a worldwide leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets will hold its 2022 Annual Shareholders' meeting on Sunday, June 26, 2022, at 7:00pm (GMT +3) at its headquarters at 120 Bethlehem Road, Jerusalem 9342001, Israel.

Amichai Glattstein, CEO of IDenta Corp, said, "We are excited about the coming annual meeting and we look forward to seeing all the attendees."

About IDenta Corp.

IDenta Corp. is a global leader in the development and supply of Field Detection and Home Diagnostics Testing Kits for Drugs & Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets. IDenta develops, manufactures and distributes revolutionary products for both the professional Law and Retail markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Safe Harbor Statement 

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Company Contact Information:
Public Relations
+1-240-545-6646
pr@identa-corp.com

Cision View original content:https://www.prnewswire.com/news-releases/identa-corp--2022-annual-meeting-301562566.html

SOURCE IDenta Corp.

FAQ

What date is IDenta Corp.'s 2022 Annual Shareholders' meeting?

IDenta Corp.'s 2022 Annual Shareholders' meeting is scheduled for June 26, 2022.

Where will IDenta Corp.'s Annual Shareholders' meeting take place?

The meeting will be held at IDenta Corp.'s headquarters in Jerusalem, Israel.

What time is the Annual Shareholders' meeting for IDenta Corp.?

The Annual Shareholders' meeting for IDenta Corp. will start at 7:00 PM (GMT +3).

What is IDenta Corp.'s main focus in the market?

IDenta Corp. focuses on the development of testing kits for narcotics, explosives, and forensic products.

Who is the CEO of IDenta Corp.?

The CEO of IDenta Corp. is Amichai Glattstein.

IDENTA CORP

OTC:IDTA

IDTA Rankings

IDTA Latest News

IDTA Stock Data

1.42M
4.05M
Diagnostics & Research
Healthcare
Link
United States of America
Jerusalem